Article

Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials.

Centre for Kidney Research, Children's Hospital at Westmead, University of Sydney, Westmead, NSW 2145, Australia.
The Journal of Urology (Impact Factor: 3.75). 08/2003; 170(1):196-200; discussion 200. DOI: 10.1097/01.ju.0000072341.34333.43
Source: PubMed

ABSTRACT We sought to determine the benefits and harms of interventions for children with daytime urinary incontinence.
Trials of any interventions for children with primary daytime incontinence (the urge syndrome and/or dysfunctional voiding) were identified from the Cochrane Controlled Trials Register, MEDLINE, EMBASE, reference lists of articles, abstracts from conference proceedings and contact with known experts in the field. Once identified, trial quality was assessed, data were extracted and results were expressed in terms of relative risks (RR) with 95% confidence intervals (CI) for individual trials, and summary estimates were obtained using a random effects model. All steps were done by 2 independent reviewers.
Randomized trials of terodiline (2 studies), daytime alarms (1), imipramine (1) and biofeedback/oxybutynin (1) involving 383 children were reviewed. No intervention was demonstrated to be effective. In the latter trial, which was the only one to evaluate a currently used intervention, after 9 months of treatment there was no difference in the proportions of children with unimproved daytime wetting with oxybutynin (RR 0.74, CI 0.26 to 2.13) and biofeedback (0.92, 0.59 to 1.43) compared with placebo.
No intervention tested in a trial to date has been proved to be of benefit to children with daytime urinary incontinence.

Download full-text

Full-text

Available from: JF Knight, Apr 24, 2014
0 Followers
 · 
80 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Until now no confirmatory clinical trial in children suffering from nonneurogenic overactive bladder (OAB) and urinary incontinence could demonstrate superiority for antimuscarinics over placebo. The following study was conducted to prove efficacy and tolerability of propiverine compared to placebo. A randomized, double-blind, placebo-controlled phase 3 trial with parallel-group design in children aged 5-10 yr was performed. Prior to the 8-wk medical therapy urologic baseline diagnostics, a 3-wk lifestyle advice (urotherapy) was established. After re-evaluation of in- and exclusion criteria and uroflowmetry, only children fulfilling the requested criteria were allocated to a body-weight-adjusted therapy (10 or 15 mg propiverine twice daily or corresponding placebo). Efficacy parameters derived from bladder diary and a micturition volume protocol. Decrease in voiding frequency per day was chosen as primary efficacy parameter; secondary endpoints included voided volume and incontinence episodes. A safety assessment was conducted. Of 171 randomized children, 87 were treated with propiverine and 84 with placebo. The primary efficacy parameter showed a decrease in voiding frequency (-2.0 episodes for propiverine versus -1.2 for placebo; p=0.0007). Superiority could also be demonstrated for voided volume (31.4 vs. 5.1 ml; p<0.0001) and incontinence episodes (-0.5 vs. -0.2 episodes per d; p=0.0005). The trial design did not allow for separate evaluation of the effect of urotherapy prior to medical treatment. Propiverine was well-tolerated in children. Altogether 23% of side-effects were reported for propiverine and 20% for placebo. This clinical trial showed superior efficacy of propiverine over placebo and good tolerability for the treatment of children suffering from OAB and urinary incontinence. An important additional factor for the success of the trial was a modified trial design with previous urotherapy. ClinicalTrials.gov Identifier: NCT00603343.
    European Urology 05/2008; 55(3):729-36. DOI:10.1016/j.eururo.2008.04.062
  • [Show abstract] [Hide abstract]
    ABSTRACT: Earlier advances in air separation and liquefaction include improvements in: overall product recovery, feed air purification, more efficient heat exchange, optimum plant control, gradual improvement in efficiency of compressors and expanders. More recent improvements include use of structured packing in distillation columns, molecular sieve adsorbents for air purification, computer simulation and control of plants, and increased machinery efficiency. Advances in fabrication and construction techniques are aimed at reducing capital costs. This paper reviews modern developments in air separation and liquefaction and attempts in this context to suggest features that might be expected to arise in the early part of the third millennium.RésuméLes premières améliorations dans la séparation et la liquéfaction d'air ont porté sur : les rendements d'extraction, la purification de l'air d'alimentation, l'efficacité des échanges thermiques, la régulation optimale des installations, et l'amélioration régulière des performances des turbines et des compresseurs. Plus récemment, ont été introduits : les garnissages pour les colonnes de distillation, les tamis moléculaires pour la prépurification, la simulation pour le contrôle des procédés, ainsi qu'une performance des équipements accrue. On a également réalisé des progrès dans le domaine de la fabrication et de la construction, permettant ainsi des économies d'investissement. Cette communication passe en revue les progrès récents dans la liquéfaction et la séparation d'air, et tente, à partir de là, d'évaluer les tendances dans la première partie du troisième millénaire.
    International Journal of Refrigeration 01/2002; DOI:10.1016/S0140-7007(01)00003-2